Haemophilia A: Low dose emicizumab effective, will reduce cost by over 50 pc, says ICMR study
New Delhi, June 24 (IANS) Low dose of emicizumab could be as effective as standard dose against Haemophilia A, according to a study led by the Indian Council of Medical Research (ICMR).Emicizumab is a bispecific monoclonal antibody used to treat hemophilia A -- a genetic bleeding disorder.The drug works by mimicking the function of the missing or…
Read More...